Liminatus Pharma LIMN
NASDAQ LIMN
$3.12 -0.10 (-3.11%)
At close: Oct 21, 2026 · 4:00 PM EDT

Liminatus Pharma (LIMN) Assets (2024 - 2026)

Updated

Liminatus Pharma (LIMN) reported Assets of $3.4 million for Q2 2026, up 78.3% from $1.91 million a year earlier and up 22.0% from the prior quarter.

Analysis

Liminatus Pharma (LIMN) Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Liminatus Pharma posted Assets of $512,795, down 90.5% from FY2024.

  • By year, Assets came in at $5.41 million in FY2024.
  • The Q2 2026 figure ranks as the highest quarterly Assets since Q4 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.79 million (Q1 2026), $512,795 (Q4 2025) and $1.34 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 201.06 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 135.12 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 115.83 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 49.36 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 201.13 Bn
10 Liminatus Pharma 3.07 Mn -2.92 Mn - 3.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.40 Mn
Mar 31, 2026 2.79 Mn
Dec 31, 2025 512,795.00
Sep 30, 2025 1.34 Mn
Jun 30, 2025 1.91 Mn
Dec 31, 2024 5.41 Mn
API Access

Liminatus Pharma Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=LIMN&period=max&api_key=YOUR_API_KEY